We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$362M
AUM Growth
+$43.1M
Cap. Flow
+$14.4M
Cap. Flow %
3.97%
Top 10 Hldgs %
36.16%
Holding
98
New
2
Increased
28
Reduced
18
Closed

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Technology 16.53%
3 Communication Services 15.06%
4 Industrials 8.7%
5 Energy 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
76
Texas Instruments
TXN
$236B
$373K 0.1%
3,475
TSLA icon
77
Tesla
TSLA
$1.38T
$350K 0.1%
19,815
-2,910
-13% -$60.6K
GS icon
78
Goldman Sachs
GS
$301B
$320K 0.09%
1,425
RCM
79
DELISTED
R1 RCM Inc. Common Stock
RCM
$305K 0.08%
30,000
LADR
80
Ladder Capital
LADR
$1.25B
$296K 0.08%
17,500
SPY icon
81
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$283K 0.08%
973
BRK.B icon
82
Berkshire Hathaway Class B
BRK.B
$1.08T
$278K 0.08%
1,300
XLK icon
83
State Street Technology Select Sector SPDR ETF
XLK
$121B
$273K 0.08%
7,242
TJX icon
84
TJX Companies
TJX
$149B
$269K 0.07%
4,800
LSXMA
85
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$232K 0.06%
7,405
SIRI icon
86
SiriusXM
SIRI
$9.62B
$109K 0.03%
1,721
IMUX icon
87
Immunic
IMUX
$210M
$28K 0.01%
+250
New +$653K

Similar funds

Private Capital Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Private Capital Advisors held 98 positions worth $362M, up 14% from $319M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Private Capital Advisors deployed $14.4M of net new capital in Q3 2018, opening 2 new positions and adding to 28 existing holdings. Its largest new stake was Exelixis: 183,350 shares worth $3.25M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Eli Lilly, an estimated $10M trimmed.

  • Private Capital Advisors's largest Q3 2018 buy was Exelixis: 183,350 shares worth $3.25M.
  • Private Capital Advisors added most to DuPont de Nemours in Q3 2018, an estimated $7.64M increase.
  • Private Capital Advisors's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $10M.
  • Private Capital Advisors's ten largest holdings make up 36% of its $362M portfolio in Q3 2018.
  • Private Capital Advisors opened 2 new positions and closed 0 in Q3 2018.
  • Private Capital Advisors's portfolio value rose 14% quarter-over-quarter to $362M.

Based on Private Capital Advisors's 13F filing for Q3 2018, filed 12 Oct 2018.